All In MedTech

Device Trial Radar · NCT07838077

Modified SOLTIVE Study

Real World Data Collection With an Investigational Device for Developing and Evaluating the Clinical Performance of Algorithms in Thulium Fiber Laser Procedures

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

May 2028

Study completion May 2028

Sponsor

Lead sponsor
Olympus Corporation of the AmericasPublic (7733.T)
Sponsor type
Industry
First posted
Sep 24, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to collect procedural data during the use of the SOLTIVE™ Premium SuperPulsed Laser System in the treatment of bladder, ureteral, and kidney stones and BPH to inform the development of software algorithms.

Conditions

  • Calculi, Renal
  • Calculi, Urinary
  • Benign Prostatic Hyperplasia

Interventions

  • SOLTIVE Premium SuperPulsed Laser SystemDevice

    The SOLTIVE™ Premium SuperPulsed Laser System is a thulium fiber laser (TFL) for lithotripsy and soft tissue ablation and enucleation procedures in the treatment of renal and urinary calculi and benign prostatic hyperplasia.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety MeasureTime frame: From enrollment to the resolution of the adverse event, assessed up to 30 days.
  2. Feasibility MeasureTime frame: From procedural data collection to data entry, assessed up to 10 days.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Kansas Medical Center

    Kansas City, Kansas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.